Helge A Reisch

Title: Helge A Reisch: Innovator in Chemical Synthesis

Introduction

Helge A Reisch is a notable inventor based in Rensselaer, NY (US), recognized for his contributions to the field of chemical synthesis. He holds two patents that showcase his innovative approaches to creating specific chemical compounds. His work has implications in pharmaceuticals, particularly in the development of therapeutic agents.

Latest Patents

Reisch's latest patents include methods for the synthesis of certain hydroxamic acid compounds. This invention focuses on the synthesis of (E)-N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide, also known as PXD101 and Belinostat. The patent outlines a series of steps for the synthesis process, including sulfonamide formation, optional purification, and alkenyl-acid addition. Another significant patent involves PARP inhibitors, which provides compounds comprising a bicyclic aryl moiety, such as 2H-phthalazin-1-one or its derivatives. This invention details methods for producing and utilizing these compounds, which have potential applications in cancer treatment.

Career Highlights

Throughout his career, Helge A Reisch has worked with several prominent companies, including Icos Corporation and Deltagen Research Labs, LLC. His experience in these organizations has contributed to his expertise in chemical synthesis and innovation in the pharmaceutical industry.

Collaborations

Reisch has collaborated with notable colleagues, including Graham Beaton and Wilna J Moree. These partnerships have likely enhanced his research and development efforts, leading to significant advancements in his field.

Conclusion

Helge A Reisch is a distinguished inventor whose work in chemical synthesis has led to valuable patents with potential therapeutic applications. His contributions to the field continue to influence the development of innovative compounds in the pharmaceutical industry.